Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 3103 for “"Amyloid"”.
-
Amyloid recognition by serum amyloid P component
<p>The X-ray crystal structures of serum amyloid P component (SAP) with bound (R)-1-[6-[(R)-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]-pyrrolidine-2-carboxylic acid (Ro 63-8695) and related components have been solved to elucidate the molecular basis of the action of Ro 63-8695, a potential amyloid …
-
Anti-amyloid Antibodies as Probes of Amyloid Fibril Structure.
<p>Amyloid fibrils have been implicated in numerous human diseases including Alzheimer's disease (AD). The fibrils found in AD are formed by the misfolding and aggregation of the Aβ peptide. Amyloid fibrils are potentially important causative agents, but high-resolution structural information is …
-
IN SILICO STUDIES OF AMYLOID FORMATION AND AMYLOID STABILITY
The term “Amyloid” describes the precursor proteins misfolded and aggregated into fibril-like structures that are built by cross β-sheet subunit. The disease caused by depositing amyloid fibril in tissues and organs is called amyloidosis. Amyloidosis can not only damage tissues and organs but also …
-
Structural Characterization of Amyloid Assemblies and Amyloid Protein-lipid Interactions
Amyloids are insoluble aggregates rich in β-structure that result from the self-assembly of polypeptides in a non-native structural fold. The deposition of these aggregates onto organs has been traditionally linked to many human diseases, however the discovery of functional amyloids in nature …
-
β-amyloid neurotoxicity
… hypothesis for the present study is that $\beta$-amyloid, a protein associated with neural damage in the brains of Alzheimer's disease patients, produces free radicals which, by leading to a disruption of calcium homeostasis and neuron degeneration, play an important role in the progressive …
-
Influencing amyloid formation : biasing nucleation of amyloid-[beta] with functionalized materials
… or toxic, such as the aggregation of amyloidogenic peptides from monomers to higher order assemblies of oligomers, fibrils, and plaques. This aggregation of amyloids is associated with a variety of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease, and …
-
Insights into Mechanisms of Amyloid Toxicity: Molecular Dynamics Simulations of the Amyloid andbeta-peptide (Aandbeta) and Islet Amyloid Polypeptide (IAPP)
Aggregation of proteins into amyloid deposits is a common feature among dozens of diseases. Two such diseases that feature amyloid deposits are Alzheimer's disease (AD) and type 2 diabetes (T2D). AD toxicity has been associated with the aggregation and accumulation of the amyloid β-peptide (Aβ); Aβ …
-
Role of Whey Protein Amyloid and Amyloid-Like Aggregates in Film Formation
… Umstrukturierung von Proteinen zu funktionellen amyloiden und amyloid-artigen Aggregaten durch thermische Behandlung im sauren Milieu führt zu verbesserten Eigenschaften dieser. Dadurch werden vorteilhafte Einsatzmöglichkeiten in Lebensmittelsystemen mit oberflächenaktiver Relevanz ermöglicht. …
-
Reducing amyloid beta peptide production through regulation of amyloid precursor protein dimerization
… successive actions of β- and γ-secretase in the amyloidogenic processing pathway of APP, aggregate into neurotoxic oligomeric Aβ and amyloid plaques. The reduction of Aβ peptide formation through the inhibition of β- and γ-secretase of the amyloidogenic pathway and the activation of α-secretase …
-
Amyloid Aggregation and Mitigation
… each tied to specific proteins that form harmful amyloid deposits. Amyloid aggregation typically follows a sigmoidal kinetic curve, beginning with a slow lag phase, followed by rapid fibril growth, and eventually reaching a plateau where mature, stable fibrils are formed. However, the early stage …
-
Reliability of Longitudinal Sleep Monitoring in Amyloid-Negative and Amyloid-Positive Older Adults.
… was longitudinally assessed (over ~3.5 years) in amyloid-negative and amyloid-positive older adults using self-reported logs, questionnaires, and at-home monitoring with a single-channel electroencephalography (EEG) device. Amyloid imaging and cognitive assessments were also performed. Test-retest …
-
Molecular basis of Amyloid Disease : In silico modelling of Beta-Amyloid (Aβ) aggregation
… for this detrimental disease. According to the Amyloid hypothesis, AD is caused by the aggregation of neurotoxic Aβ which is cleaved from the C-terminal of a very large protein, the amyloid precursor protein (APP). A molecular-level understanding is critical to understanding the development and …
-
The role of SORLA in islet amyloid polypeptide transport and islet amyloid deposition
… against AD by preventing the accumulation of amyloid-beta peptides into amyloid plaque deposits in the brain. Similar to AD, amyloid is a pathological hallmark found in the pancreas of type 2 diabetes patients. The main amyloidogenic component in pancreatic islet is a small peptide hormone …
-
BACTERIAL AMYLOID CURLI INFLUENCES AGGREGATION OF AMYLOID BETA PEPTIDES ASSOCIATED WITH ALZHEIMER ́S DISEASE
Amyloid proteins are associated with various disorders such as Alzheimer's, Parkinson's, prion diseases, and type 2 diabetes. Each of these illnesses involves a specific amyloid protein or peptide that misfolds and forms fibrils. Apart from pathological amyloids, there are amyloids that are …
-
Cerebral Amyloid Angiopathy-Causing Beta-Amyloid Variants Have Altered Effects on the Clotting System
Cerebral amyloid angiopathy (CAA), where beta-amyloid (Aβ) deposits around cerebral blood vessels, is a major contributor of vascular dysfunction in Alzheimer's disease (AD) patients. However, the molecular mechanism underlying CAA formation and CAA-induced cerebrovascular pathologies, including …
-
Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.
… process in Alzheimer’s disease and other amyloid disorders usually involves the transformation of a soluble monomeric protein via potentially toxic oligomers into amyloid fibrils. The structure and properties of the intermediary oligomers have been difficult to study due to their …
-
Small Molecules as Amyloid Inhibitors: Molecular Dynamic Simulations with Human Islet Amyloid Polypeptide (IAPP)
Islet amyloid polypeptide (IAPP) is a 37-residue amyloidogenic hormone implicated in the progression of Type II Diabetes (T2D). T2D affects an estimated 422 million people yearly and is a co-morbidity with numerous diseases. IAPP forms toxic oligomers and amyloid fibrils that reduce pancreatic …
-
Amyloid-β and amyloid associated proteins in the pathology and diagnosis of Alzheimer's disease
Contains fulltext : 156484.pdf (Publisher’s version ) (Open Access)
-
Molecular Mechanism of Amyloid Inhibition
… presence of extracellular fibrillar deposits of -amyloid (A), a 38 to 42 residue protein that is produced normally as part of the cellular metabolism.
Page 1 of 156